DESC:DESCRIPTION OF THE PREFERRED EMBODIMENTS:
[0013] While the present invention is described herein by way of example using embodiments and illustrative drawings, those skilled in the art will recognize that the invention is not limited to the embodiments of drawing or drawings described and are not intended to represent the scale of the various components. Further, some components that may form a part of the invention may not be illustrated in certain figures, for ease of illustration, and such omissions do not limit the embodiments outlined in any way. It should be understood that the drawings and the detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the present invention as defined by the appended claim.
[0014] As used throughout this description, the word "may" is used in a permissive sense (i.e. meaning having the potential to), rather than the mandatory sense, (i.e. meaning must). Further, the words "a" or "an" mean "at least one” and the word “plurality” means “one or more” unless otherwise mentioned. Furthermore, the terminology and phraseology used herein are solely used for descriptive purposes and should not be construed as limiting in scope. Language such as "including," "comprising," "having," "containing," or "involving," and variations thereof, is intended to be broad and encompass the subject matter listed thereafter, equivalents, and additional subject matter not recited, and is not intended to exclude other additives, components, integers, or steps. Likewise, the term "comprising" is considered synonymous with the terms "including" or "containing" for applicable legal purposes. Any discussion of documents, acts, materials, devices, articles, and the like are included in the specification solely for the purpose of providing a context for the present invention. It is not suggested or represented that any or all these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention.
[0015] In this disclosure, whenever a composition or an element or a group of elements is preceded with the transitional phrase “comprising”, it is understood that we also contemplate the same composition, element, or group of elements with transitional phrases “consisting of”, “consisting”, “selected from the group of consisting of, “including”, or “is” preceding the recitation of the composition, element or group of elements and vice versa.
[0016] The present invention is described hereinafter by various embodiments with reference to the accompanying drawing, wherein reference numerals used in the accompanying drawing correspond to the like elements throughout the description. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiment set forth herein. Rather, the embodiment is provided so that this disclosure will be thorough and complete and will fully convey the scope of the invention to those skilled in the art. In the following detailed description, numeric values and ranges are provided for various aspects of the implementations described. These values and ranges are to be treated as examples only and are not intended to limit the scope of the claims. In addition, several materials are identified as suitable for various facets of the implementations. These materials are to be treated as exemplary and are not intended to limit the scope of the invention. The present invention relates to a skin care formulation which provides nourishment to the skin of the user.
[0017] In an embodiment of the present invention, the skin care formulation comprises of i) Whey Protein Concentrate in the range of 26% to 27% w/v, ii) Sucrolose in the range of 0.03% to 0.04% w/v, iii) Vitamin A and E complex in the range of 0.22% to 0.33% w/v, iv) Omega fatty acid complex in the range of 0.08% to 0.10% w/v, v) Hylauronic acid in the range of 0.08% to 0.09% w/v, vi) L- Isoleucine in the range of 0.17% to 0.18% w/v, vii) L–Leucine in the range of 0.17% to 0.18% w/v, viii) Green Tea extract in the range of 0.25% to 0.26% w/v xi) Gingseng extract in the range of 0.25% to 0.26% w/v, x) L-Proline in the range of 0.08% to 0.10% w/v, xi) Glycine in the range of 0.08% to 0.10% w/v, xii) Bamboo shoot extract powder in the range of 0.25% to 0.26% w/v, xiii) Vanilla extract in the range of 0.10% to 0.12% w/v xiv) Skimmed Milk Powder in the range of 37.75% to 38% w/v, xv) MCT Powder in the range of 2.5% to 2.6% w/v xvi) Stevia in the range of 0.1% to 0.2% w/v, xvii) FOS in the range of 3.9% to 4.0% w/v, xviii) Rice Starch in the range of 26.8% to 27% w/v, xix) Digestive enzyme mix in the range of 0.1% to 0.2%, xx) Xanthan Gum in the range of 0.17% to 0.18%.
[0018] In another embodiment of the present invention the method for preparation of the skin care formulation involves the mixing of all the disclosed components in provided amounts.
[0019] Example:
Table below discloses the usage and the amount of components that are to be added in the formulation disclosed above.
Serving size 8 grams
Total servings 30
for 100 grams for 8 grams % RDA
Energy (KCal) 333.58 26.69 1.15%
Carbohydrates (g) 48.02 3.84 **
Dietary fibre (g) 3.5 0.28 **
Protein (g) 27.5 2.20 3.68%
Total fat (g) 3.5 0.28 2.73%
Silica (mg) 128 10.24 **
Vitamin A (µg RE) 183.21 14.66 8.14%
Vitamin E (mg - TE) 3.05 0.244 8.14%
Vitamin D (µg) 3.05 0.244 9.76%
Omega- 3 fatty acids (mg) 0.02 0.001 **
Omega-6 fatty acids (mg) 0.02 0.001 **
Omega- 9 fatty acids (mg) 0.02 0.001 **
% RDA values established as per ICMR guide lines
** RDA values not established
Recommed usage = 8 gms (per d ay)
Recommended usage depends on physiology of an individual
Do not exceed recommended daily usage

[0020] Various modifications to these embodiments are apparent to those skilled in the art from the description and the accompanying drawings. The principles associated with the various embodiments described herein may be applied to other embodiments. Therefore, the description is not intended to be limited to the 5 embodiments shown along with the accompanying drawings but is to be providing the broadest scope consistent with the principles and the novel and inventive features disclosed or suggested herein. Accordingly, the invention is anticipated to hold on to all other such alternatives, modifications, and variations that fall within the scope of the present invention and appended claims.
,CLAIMS:1. A skin care formulation which provides nourishment to the skin of the user comprising of i) Whey Protein Concentrate, ii) Sucrolose, iii) Vitamin A and E complex, iv) Omega fatty acid complex, v) Hylauronic acid, vi) L- Isoleucine, vii) L–Leucine, viii) Green Tea extract, xi) Gingseng extract, x) L-Proline, xi) Glycine, xii) Bamboo shoot extract powder, xiii) Vanilla extract, xiv) Skimmed Milk Powder, xv) MCT Powder, xvi) Stevia, xvii) FOS, xviii) Rice Starch, xix) Digestive enzyme mix and xx) Xanthan Gum.
2. The formulation as claimed in claim 1, wherein i) Whey Protein Concentrate is in the range of 26% to 27% w/v, ii) Sucrolose is in the range of 0.03% to 0.04% w/v, iii) Vitamin A and E complex is in the range of 0.22% to 0.33% w/v, iv) Omega fatty acid complex is in the range of 0.08% to 0.10% w/v, v) Hylauronic acid is in the range of 0.08% to 0.09% w/v, vi) L- Isoleucine is in the range of 0.17% to 0.18% w/v, vii) L–Leucine is in the range of 0.17% to 0.18% w/v, viii) Green Tea extract is in the range of 0.25% to 0.26% w/v xi) Gingseng extract is in the range of 0.25% to 0.26% w/v, x) L-Proline is in the range of 0.08% to 0.10% w/v, xi) Glycine is in the range of 0.08% to 0.10% w/v, xii) Bamboo shoot extract powder is in the range of 0.25% to 0.26% w/v, xiii) Vanilla extract is in the range of 0.10% to 0.12% w/v xiv) Skimmed Milk Powder is in the range of 37.75% to 38% w/v, xv) MCT Powder is in the range of 2.5% to 2.6% w/v xvi) Stevia is in the range of 0.1% to 0.2% w/v, xvii) FOS is in the range of 3.9% to 4.0% w/v, xviii) Rice Starch is in the range of 26.8% to 27% w/v, xix) Digestive enzyme mix is in the range of 0.1% to 0.2%, xx) Xanthan Gum is in the range of 0.17% to 0.18%.
3. A method of preparing the formulation as claimed in claim 1, comprises the steps of mixing of all the disclosed components in provided amounts.